Immunometabolic Reprogramming in Rheumatoid Arthritis: Mechanistic Evidence, Candidate Biomarkers, and Translational Challenges

Authors: Li, Hui; Li, Ning

Source journal: Journal of inflammation research (2026-01-01)

DOI: 10.2147/JIR.S639333

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease in which inflammatory signaling and cellular metabolism interact within the synovial microenvironment. This narrative review critically examines glucose, lipid and amino-acid metabolism, mitochondrial dysfunction, and their cell-specific roles in synovial fibroblasts, macrophages, lymphocytes and other joint-resident or infiltrating cells. Human tissue and observational metabolomic studies support the presence of metabolic alterations in RA, whereas causal mechanisms are established predominantly through experimental perturbation in cell-based and animal models. Lactate, lipid signatures, kynurenine-pathway metabolites and oxidative-stress measures are promising candidate biomarkers, but none of the metabolic endotypes discussed here is established as a clinically validated tool for treatment selection. Methotrexate and approved disease-modifying antirheumatic drugs remain the clinical standard; direct glycolytic or glutaminolytic inhibitors, repurposed metabolic modulators, traditional Chinese medicine interventions, stimulus-responsive carriers, and nucleic-acid or gene-based approaches require substantially more RA-specific clinical validation. We synthesize the evidence by model and translational maturity, highlight conflicting or context-dependent observations, and identify key barriers including cohort heterogeneity, assay standardization, off-target toxicity and prospective validation. The resulting framework positions immunometabolism as a testable contribution to RA biology rather than an established precision-treatment algorithm.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.